| Griswold Medical Center Rhc | |
|
1501 E 10th St Atlantic IA 50022-1936 | |
| (712) 243-2850 | |
| (712) 243-7423 |
| Full Name | Griswold Medical Center Rhc |
|---|---|
| Speciality | Family Medicine |
| Location | 1501 E 10th St, Atlantic, Iowa |
| Authorized Official Name and Position | Abbey Stangl (CHIEF FINANCIAL OFFICER) |
| Authorized Official Contact | 7122433250 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Griswold Medical Center Rhc 1109 Morningside Drive Griswold IA 51535-0099 Ph: (712) 778-5140 | Griswold Medical Center Rhc 1501 E 10th St Atlantic IA 50022-1936 Ph: (712) 243-2850 |
| NPI Number | 1316148307 |
|---|---|
| Provider Enumeration Date | 05/29/2007 |
| Last Update Date | 01/16/2023 |
| Medicare PECOS PAC ID | 5294634994 |
|---|---|
| Medicare Enrollment ID | O20070605000089 |
News Archive
Late-breaking Novo Nordisk extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association showed that once-daily Victoza in combination with metformin produced sustained and significantly greater reductions in A1c, body weight and fasting plasma glucose than Januvia plus metformin at 52 weeks.
By determining the three-dimensional structure of proteins at the atomic level, researchers at the National Institutes of Health have discovered how some commonly used flame retardants, called brominated flame retardants (BFRs), can mimic estrogen hormones and possibly disrupt the body's endocrine system. BFRs are chemicals added or applied to materials to slow or prevent the start or growth of fire.
Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2 in the peer-reviewed medical journal CHEST¸ the official journal of the American College of Chest Physicians, titled: Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC trial.
Why the skeleton starts to fail us as we age and what drugs of the future will do to build and maintain our bones, will be discussed at a free public lecture at the University of Melbourne tomorrow (August 10).
Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316148307 | NPI | - | NPPES |
| 1316148307 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Secondary |
News Archive
Late-breaking Novo Nordisk extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association showed that once-daily Victoza in combination with metformin produced sustained and significantly greater reductions in A1c, body weight and fasting plasma glucose than Januvia plus metformin at 52 weeks.
By determining the three-dimensional structure of proteins at the atomic level, researchers at the National Institutes of Health have discovered how some commonly used flame retardants, called brominated flame retardants (BFRs), can mimic estrogen hormones and possibly disrupt the body's endocrine system. BFRs are chemicals added or applied to materials to slow or prevent the start or growth of fire.
Integrated Diagnostics today announced the e-publication of full results of a large prospective clinical trial validating its Xpresys Lung 2 in the peer-reviewed medical journal CHEST¸ the official journal of the American College of Chest Physicians, titled: Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC trial.
Why the skeleton starts to fail us as we age and what drugs of the future will do to build and maintain our bones, will be discussed at a free public lecture at the University of Melbourne tomorrow (August 10).
Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.
› Verified 9 days ago
Anita Medical Center Rural Health Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1501 E 10th St, Atlantic, IA 50022 Phone: 712-243-2850 Fax: 712-243-7423 | |
Atlantic Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1501 E 10th St, Ste 100, 105 & 120, Atlantic, IA 50022 Phone: 712-243-2850 Fax: 712-243-7423 | |
Atlantic Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 E 10th St Ste 100, Atlantic, IA 50022 Phone: 712-243-2850 Fax: 712-243-7423 |